上海润诺生物科技有限公司招聘信息、联系方式

成立时间：2005 年
所属行业：制药/生物工程
企业性质：外商独资
注册资金：4000 万元
员工人数：200-500人
所在地址：上海 - 浦东
浏览次数：2163 次
更新时间：2016-4-22

上海润诺生物科技有限公司的简介

关于保诺
保诺科技是Bridgewest企业集团（以下简称“BBG”）旗下一家领先的生命科学研发公司，专业为生物制药客户提供从靶标识别到0期的一体化药物研发服务。保诺科技在大小分子发现和专利技术平台方面拥有深厚而丰富的治疗专业知识，在大幅度加快客户先导化合物发现项目的进度方面拥有得天独厚的条件。
总部设于加利福尼亚州圣地亚哥。保诺科技于2005年在北京成立，并于2012年和2013年先后在上海和南京建立全资子公司和创新药研发中心。在圣地亚哥，北京、上海、南京三地拥有近600名员工。保诺科技目前在北京中关村生命科学园和上海自贸区分别拥有面积达10,000平方米和9,200平方米的国际一流水准的实验室，并拥有一支经验丰富的高素质研发人员和科学家队伍。其中20%拥有博士学位，15%具有海外经验。
保诺科技在中国生物医药研发外包机构中拥有最深厚的药物发现专业知识，在化学、药研生物学、药物代谢及药代动力学（DMPK）、药理学以及一体化临床前研发服务领域拥有雄厚的实力，可为客户的药物研发项目提供最优秀的创新解决方案。在小分子药物研发领域通过与X-Chem Inc.公司建立战略合作伙伴关系，保诺科技可利用X-Chem拥有专利技术的DNA化学库发现创新型苗头和先导化合物，为客户提供丰富的化合物库，在更大范围内探寻重要的药物靶标，可加快先导化合物的发现进程，提高成功概率。
BBG是一家在全球范围内专注于生物技术与高科技领域投资的封闭型控股公司。凭借其管理的超过15亿美元的资金，BBG通过应用其深厚的行业知识、卓越的运营技能以及充裕的资金资源持续地战略性投资于能够产生长期价值回报的领域。BBG旗下还拥有Formex, BioAtla, Femta, Molecular Response等单抗技术平台公司，生物科技公司以及药物制剂和生产服务公司。其中的Formex具有世界领先的制剂研发技术水平。2015年7月，Formex与BioDuro成功合并，将保诺新药研发服务领域从临床前延伸到临床领域。在BBG的带领下保诺科技将一如既往提高核心竞争力、扩展服务功能并提高服务能力、持续培养员工以提高研发水平，将成为药物研发服务业内最好的国际化公司作为我们持之以恒的目标。
上海公司
上海润诺生物科技有限公司（以下简称“润诺科技”）是由保诺科技在上海投资设立的全资子公司，位于上海自由贸易区内之外高桥保税区。同母公司保诺科技一样，润诺科技专注于提供新药研发服务。公司设药物化学、药代动力学、药研生物学、药效学等专业研发部门和运营团队，拥有国际一流技术与设施配备的7,200平米实验室和2000平米办公楼。公司实验室中2,000平米专门进行大型动物和小型动物实验的动物房已通过AAALAC认证。公司目前有150多名员工，并且正在快速成长之中。

About BioDuro
BioDuro, a Bridgewest company, is a leading life sciences research organization that provides biopharmaceutical clients with comprehensive, integrated drug discovery services spanning from target identification through Phase 0. With depth and breadth of therapeutic expertise in small molecule discovery, and large molecular development and scale up, combined with unique technology platforms, BioDuro is well positioned to help clients significantly accelerate their lead discovery programs.
With its headquarters located in Santiago, California, the company was established in Beijing in 2005. It opened its branches and drug discovery center in Shanghai and Nanjing in 2012 and 2013 respectively. BioDuro’s global operations include a total of nearly 600 employees in Santiago, Beijing, Shanghai and Nanjing. It has a 100,000 sf facility in Beijing, a 92,000 sf state of the art facility in Shanghai, and a team of highly experienced research staff and scientists, of whom 20% own Phd degree and 15% overseas background.
With the highest concentration of drug discovery expertise of any contract research organization (CRO) in China and a broad range of capabilities in chemistry, discovery biology, drug metabolism and pharmacokinetics (DMPK), pharmacology, as well as integrated preclinical research and development services, BioDuro brings superior insight and innovative solutions to its clients’ drug discovery programs. Through a strategic partnership with X-Chem Inc., BioDuro is able to conduct innovative hit and lead generation by using its proprietary DNA-based chemical libraries, giving the clients access to large, diverse libraries of compounds that can be used to better interrogate a broad range of high priority drug targets, which can significantly accelerate lead discovery and improve the probability of success.
The Bridgewest Group (BBG) is a closely held investment company with global assets in the biotech and hi-tech industries. With its managed fund of more than 1.5 billion USD, BBG creates long-term value through the application of superior industry knowledge, operational expertise and significant financial resources to attractive investment opportunities. The subsidiary companies of BBG also include monoclonal antibody technique platform companies, biotech companies and pharmaceutical preparation and manufacturing companies such as Formex, BioAtla, Femta, Molecular Response, etc. Among them, Formex is a leading contract development and manufacturing organization. In July, 2015, Formex merged with BioDuro, which extended BioDuro’s new drug discovery service from pre-clinical stage to clinical field. Under the leadership of BBG, BioDuro will continue to improve its core competitiveness, expand and enhance its services and cultivate its employees to increase their research and development ability, aiming at becoming the best international drug discovery and service company of the industry.

BioDuro (Shanghai)
BioDuro (Shanghai) is a wholly-owned subsidiary of BioDuro, located at the Waigaoqiao Free Trade Zone. Same as its parent company, BioDuro (Shanghai) focuses on providing new drug discovery service. The company houses pharmaceutical chemistry, DMPK, and integrated biology and pharmacology as well as an operational team. It owns a 7,200 square meters state of the art laboratory and a 2,000 square meters office building. The 2,000 square meters laboratory for animal experiment has been approved by the AAALAC. Currently, the company has more than 150 employees and is growing rapidly.

上海润诺生物科技有限公司的招聘职位

职位名称
工作地址
性别
截止时间
招聘人数
月薪
投递简历

温馨提示：以上上海润诺生物科技有限公司的招聘信息来自台湾人才网，效果会更好！台湾人才网打造台湾地区最大，最专业的台湾人才网！

上海润诺生物科技有限公司的联系方式

台湾人才网特别提醒：

1、在面试时可先在百度或者谷歌搜索一下该公司的相关信息，查看公司的基本情况，确定是否为虚假招聘信息！
点击这里在百度搜索上海润诺生物科技有限公司相关信息
2、本页面的招聘信息由会员自行发布，真实性由发布人负责，但若发现招聘信息不实，请您向本站检举，我们将立即核实并处理！
3、任何以招聘名义向求职者收取费用的行为都是违法的，请求职者在求职过程中勿向招聘单位交纳任何费用，包括培训费、
资料费、信息费等，如求职者自愿向企业缴纳相关费用，台湾人才网不承担任何责任。
4、如果该公司隐藏联系方式，请注册简历后直接在线发送简历 ,系统将会自动投送您的简历！

上一个招聘企业：深圳化妆培训,深圳色彩培训学校
下一个招聘企业：申博太阳城